Skip to Main Content

Paper Details

Betacellulin drives therapy resistance in glioblastoma.
Neuro Oncol
8
2020
BTC, Betacellulin, EGFR, EGFR-ligand protein, GBM, GBM cells, GBM43, GBM8, Human, Human glioblastoma cell lines, LN229, NF-B, PDXs, SF767, STAT3, U373, U87, betacellulin, derived xenografts, epidermal growth factor receptor, glioblastoma, mice, nuclear factor-kappaB, osimertinib, phospho, signal transducer and activator of transcription 3, tumor, tyrosine
Author NameAffiliation
Kevan M ShokatUniversity of California San Francisco
Trever G BivonaHelen Diller Family Comprehensive Cancer Center
William A WeissUniversity of California San Francisco (UCSF)
William A WeissHelen Diller Family Comprehensive Cancer Center
William A WeissUniversity of California San Francisco
William A WeissUniversity of California San Francisco
William A WeissUniversity of California San Francisco (UCSF)
William A WeissHelen Diller Family Comprehensive Cancer Center
William A WeissUniversity of California San Francisco
William A WeissUniversity of California San Francisco
  • 1 - 10

Datasets

Release 1.2